Concepedia

Publication | Open Access

Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor–Positive, HER2-Negative Advanced Breast Cancer

DOIFull Paper Access

108

Citations

17

References

2018

Year

Guy Jérusalem, Richard H. De Boer, Sara A. Hurvitz, Denise A. Yardley, Bent Ejlertsen, Sibel Blau, Mustafa Özgüroğlu, László Landherr, Marianne Ewertz, Tetiana Taran,
JAMA Oncology

Abstract

ClinicalTrials.gov identifier: NCT01783444.

References

YearCitations

Page 1